VolitionRx Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 0.039752 million compared to USD 0.024782 million a year ago. Net loss was USD 7.65 million compared to USD 5.53 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.1 a year ago. Diluted loss per share from continuing operations was USD 0.14 compared to USD 0.1 a year ago.
For the six months, revenue was USD 0.153963 million compared to USD 0.050312 million a year ago. Net loss was USD 15.28 million compared to USD 11.64 million a year ago. Basic loss per share from continuing operations was USD 0.28 compared to USD 0.22 a year ago. Diluted loss per share from continuing operations was USD 0.28 compared to USD 0.22 a year ago.